Investors rush to patent genetically modified cannabis molecules
Monday, October 15, 2018 - 01:24
in Biology & Nature
Biotechnology companies and drug producers are trying to isolate and patent the active chemicals in cannabis, potentially creating new medicines. That has critics raising "bio piracy" fears, as the once-illicit industry becomes mainstream.